ABL Diagnostics calls Sept. 17 shareholder vote on Euronext Paris to Euronext Growth listing shift

• ABL Diagnostics set a Sept. 17, 2026 shareholder meeting to vote on moving its share listing from Euronext Paris to Euronext Growth Paris.
• The agenda also includes a vote on changing the company’s corporate name.
• Meeting scheduled for 11:00 a.m. in Paris.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202608271200BIZWIRE_USPR_____20260827_BW338908) on August 27, 2026, and is solely responsible for the information contained therein.